Energy-Based Ablation Devices Market Size, Share, Growth and Industry Analysis by Type (Electrical, Light, Radiation, Radiofrequency, Ultrasound, And, Other), By Application (Ophthalmic Surgery, General Surgery, Cancer Therapy, Cardiovascular Disease, And, Other) Regional Insights and Forecast to 2031

Updated On: 08 April 2024

ENERGY-BASED ABLATION DEVICES MARKET REPORT OVERVIEW

• 

• Request a Free Sample to learn more about this report

The global energy-based ablation devices market size was USD 5649.1 million in 2022 and will touch USD 9479.3 million by 2028, exhibiting a CAGR of 9.0% during the forecast period.

Energy-based ablation devices use various forms of energy, such as radiofrequency, laser, or microwave, to precisely remove or destroy tissues. These devices are employed in medical procedures to treat conditions like tumors, abnormal heart rhythms, or unwanted tissue growth. By delivering controlled energy to targeted areas, they enable minimally invasive interventions, reducing the need for extensive surgery.

The precision of these devices minimizes damage to surrounding healthy tissues and promotes quicker recovery times for patients. As technology advances, energy-based ablation continues to play a crucial role in enhancing therapeutic options across different medical specialties. All of these factors have played an important role in increasing market growth.

COVID-19 impact: Prioritization of COVID-19 Solutions During Pandemic Decreased Market Growth

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.

The COVID-19 pandemic has influenced the utilization of energy-based ablation devices in healthcare. Elective procedures, including many that involve these devices, faced disruptions due to resource reallocation and safety concerns. Hospitals prioritized COVID-19 cases, leading to a decrease in non-essential interventions. This impacted the demand for energy-based ablation devices, affecting manufacturers and healthcare providers alike. However, the pandemic also accelerated the adoption of telemedicine, influencing how these devices are monitored and operated remotely. As healthcare systems adapt to the new normal, the role and usage of energy-based ablation devices may undergo further transformations in a post-pandemic landscape.

LATEST TRENDS

"Integration of Advanced Technologies, Such as Artificial Intelligence and Robotics to Fuel Market Growth"

Innovations in energy-based ablation devices are reshaping medical interventions. Advanced technologies, such as artificial intelligence and robotics, are enhancing precision and control during procedures. Nanotechnology is facilitating targeted delivery of energy, minimizing collateral damage to surrounding tissues. Furthermore, improved imaging techniques, like real-time MRI guidance, provide better visualization for accurate device placement. The integration of smart sensors allows real-time monitoring and adjustment, ensuring optimal treatment outcomes. These innovations collectively contribute to the evolution of energy-based ablation devices, offering healthcare professionals more effective tools for minimally invasive interventions with reduced risks and improved patient outcomes. All of these factors are driving the energy-based ablation devices market growth.

ENERGY-BASED ABLATION DEVICES MARKET SEGMENTATION

• 

• Request a Free Sample to learn more about this report

• By Type

Based on type the global market is segmented into electrical, light, radiation, radiofrequency, ultrasound, and, other

Electrical: Electrical energy-based ablation devices utilize electrical currents to target and treat specific tissues. This segment includes technologies like electrosurgery, where high-frequency electrical currents cut or coagulate tissues. Precise control over the electrical energy allows for diverse medical applications, from surgical procedures to tissue removal.

Light:  Light-based ablation involves the use of lasers for precise tissue removal or alteration. Laser ablation is common in dermatology, ophthalmology, and various surgical fields. The focused and intense light energy enables accurate and controlled procedures with minimal damage to surrounding tissues.

Radiation: Radiation-based ablation devices employ ionizing radiation to target and destroy abnormal tissues, commonly used in cancer treatment. Techniques like radioembolization and stereotactic body radiation therapy offer minimally invasive alternatives for patients with certain tumors, providing localized treatment with reduced impact on healthy tissues.

Radiofrequency: Radiofrequency ablation uses high-frequency electrical currents to generate heat, causing thermal destruction of targeted tissues. Widely used in cardiology and interventional radiology, this technique treats conditions like cardiac arrhythmias or liver tumors. Its ability to create precise lesions makes it valuable for therapeutic interventions.

Ultrasound: Ultrasound-based ablation devices utilize focused ultrasound waves to generate heat, enabling non-invasive tissue ablation. This technology finds applications in treating uterine fibroids, prostate conditions, and neurological disorders. The ability to target tissues deep within the body without incisions contributes to its appeal in various medical specialties.

Other: The "Other" segment encompasses emerging and miscellaneous technologies within energy-based ablation. This may include innovative approaches like cryoablation (using extreme cold), microwave ablation, or combination therapies. Ongoing research and development continue to expand this category, introducing novel techniques for diverse medical applications.

• By Application

Based on application the global market is segmented into ophthalmic surgery, general surgery, cancer therapy, cardiovascular disease, and, other

Ophthalmic surgery: Energy-based ablation devices play a vital role in ophthalmic surgery, addressing conditions like cataracts or refractive errors. Lasers, for instance, are used in procedures like laser-assisted in situ keratomileusis (LASIK), providing precise corneal reshaping. These devices contribute to improved outcomes and reduced recovery times in various eye surgeries.

General surgery:  In general surgery, energy-based ablation devices find broad applications. Electrosurgical tools are used for cutting, coagulation, and tissue removal, ensuring precision and minimizing bleeding during procedures. Additionally, advanced technologies like radiofrequency ablation play a crucial role in minimally invasive surgeries, enhancing patient recovery.

Cancer therapy: Energy-based ablation devices are integral to cancer therapy, offering minimally invasive alternatives. Radiofrequency ablation and laser therapy target tumors with precision, providing therapeutic options for patients who may not be suitable for traditional surgery. These technologies contribute to localized treatment with reduced impact on healthy tissues.

Cardiovascular disease: Cardiovascular applications of energy-based ablation devices are prominent, especially in treating cardiac arrhythmias. Techniques like radiofrequency ablation are utilized to create lesions that disrupt abnormal electrical pathways, restoring normal heart rhythm. These devices significantly impact the management of cardiovascular diseases, providing alternatives to invasive surgical procedures.

Other: The "Other" category encompasses diverse medical specialties where energy-based ablation devices find applications beyond the mentioned segments. This may include specialties like dermatology, gastroenterology, or urology, where these devices contribute to a range of therapeutic interventions, expanding their role in modern medical practices.

DRIVING FACTORS

"Collaborative Efforts between Medical Professionals, Engineers, And Researchers to Amplify Market Growth"

The evolution of energy-based ablation devices is propelled by several key factors. Technological advancements, such as enhanced precision through robotics and artificial intelligence, drive innovation. Growing demand for minimally invasive procedures fosters the development of more efficient and targeted devices. Increased awareness of the benefits, including quicker recovery and reduced complications, further fuels adoption.

Additionally, collaborative efforts between medical professionals, engineers, and researchers contribute to continuous refinement. Rising incidences of conditions like tumors and cardiac arrhythmias necessitate advanced treatment options, pushing manufacturers to create increasingly sophisticated energy-based ablation devices. The intersection of technology, medical needs, and collaborative research is steering the evolution of these devices. The above-mentioned factors are promoting energy-based ablation devices market share.

"Patient Preferences for Treatments with Fewer Side Effects to Drive Market Growth"

Economic considerations play a pivotal role in the advancement of energy-based ablation devices, as healthcare systems seek cost-effective solutions that minimize hospital stays and recovery times. Regulatory support and streamlined approval processes encourage manufacturers to invest in research and development. Global demographic shifts, particularly aging populations, drive the demand for less invasive interventions.

Furthermore, patient preferences for treatments with fewer side effects propel the industry forward. The quest for improved safety profiles and expanded applications, coupled with competitive markets, compels companies to continually innovate. These multifaceted factors collectively steer the trajectory of energy-based ablation devices, shaping the future of medical interventions.

RESTRAINING FACTOR

"Regulatory Hurdles, Stringent Approval Processes, and Reimbursement Issues to Deteriorate Market Growth"

Despite advancements, energy-based ablation devices face challenges. Cost barriers limit accessibility, hindering widespread adoption. Regulatory hurdles, stringent approval processes, and reimbursement issues slow down market entry. Concerns over potential side effects and long-term safety may create hesitancy among both practitioners and patients. Variability in operator skill levels affects consistent outcomes.

Technical complexities and the learning curve associated with newer technologies can impede swift integration. Additionally, competition within the medical device industry demands continuous refinement and validation, delaying product launches. These restraining factors collectively pose challenges to the seamless incorporation of energy-based ablation devices into mainstream medical practice.

ENERGY-BASED ABLATION DEVICES MARKET REGIONAL INSIGHTS

• 

• Request a Free Sample to learn more about this report

"North America to Dominate Market Due to Robust Healthcare Infrastructure"

The market is primarily segregated into Europe, Latin America, Asia Pacific, North America, and Middle East & Africa.

North America especially, the U.S. stands as a leading region in the development and utilization of energy-based ablation devices. A robust healthcare infrastructure, coupled with significant investments in research and development, propels innovation. The presence of key market players and academic institutions fosters collaboration, driving advancements in technology.

Additionally, favorable reimbursement policies and a proactive regulatory environment contribute to the widespread adoption of these devices. The high prevalence of chronic conditions necessitates advanced medical interventions, further boosting the prominence of energy-based ablation devices in the United States, making it a pivotal hub for their evolution and application.

Key Industry Players

"Leading Players adopt Acquisition Strategies to Stay Competitive "

Several players in the market are using acquisition strategies to build their business portfolio and strengthen their market position. In addition, partnerships and collaborations are among the common strategies adopted by companies. Key market players are making R&D investments to bring advanced technologies and solutions to the market.

List of Market Players Profile

• Abbott EP (U.S.)
• AngioDynamics, Inc. (U.S.)
• AtriCure, Inc. (U.S.)
• biolitec AG (Germany)
• Biosense Webster, Inc. (U.S.)
• Boston Scientific Corporation (U.S.)
• BTG Plc (UK)
• Cardiogenesis Corporation (U.S.)
• Cynosure, Inc. (U.S.)
• Conmed Corporation (U.S.)
• EDAP TMS S.A. (France)
• Ethicon Endo-Surgery, Inc. (U.S.)
• Halyard Health, Inc. (U.S.)
• InSightec® Ltd.
• Integra LifeSciences Corporation (U.S.)
• Lumenis Ltd.
• Medtronic, Plc
• Monteris Medical, Inc. (U.S.)
• Olympus America, Inc. (U.S.)
• Sichuan Jinjiang Electronic Science and Technology Co., Ltd. (China)
• SonaCare Medical LLC (U.S.)
• Smith & Nephew Plc (UK)
• Stryker Corporation (U.S.)
• Syneron & Candela (U.S.)
• Varian Medical Systems, Inc. (U.S.)

INDUSTRIAL DEVELOPMENT

November 2022: Recent research highlights a groundbreaking advancement in the form of pulsed field ablation (PFA), a novel technology poised to address prevalent challenges. Diverging from traditional thermal approaches, PFA employs an electrical field delivered in rapid bursts, inducing irreversible electroporation (IRE) in tissues. This innovative technique destabilizes cardiomyocyte cell membranes, causing targeted cell death without affecting the smooth muscle of the esophagus and nerve axons. This precision has the potential to eliminate complications associated with existing methods. Additionally, PFA demonstrates a notable reduction in pulmonary vein (PV) narrowing compared to conventional thermal ablation, marking a significant stride in enhancing therapeutic outcomes.

Report Coverage

The report provides an insight into industry from both the demand and supply sides. Further, it also gives information on the impact of COVID-19 on the market, the driving and the restraining factors along with the regional insights. Market dynamic forces during the forecast period have also been discussed for the better understanding of the market situations. The report also lists the key industry players to understand the competition.